DMD and Duchenne muscular dystrophy: Exon-skipping and gene-therapy development for DMD patients assume that by increasing expression of partial dystrophin in tissue, DMD patients will experience a milder, more BMD-like phenotype with increased mobility and prolonged life expectancy.